Login

Brickworks Ltd MD Discusses Full Year Results, Property Trust, and Dividend Policy with Tom Piotrowski | Lindsay Partridge - CEO of brickworks ltd 00:10:00

Share On Facebook Share On Twitter

Lindsay Partridge is the CEO of brickworks ltd

Recent Videos

00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper

Suggestions

00:10:00
Peter Pawlowitsch, Chairman of Dubber Corporation (ASX), outlines the company's strategy and future outlook at the ASX Spotlight Series in Hong Kong.|Peter Edward Pawlowitsch is currently the Chief Executive Officer at Dubber Corp Ltd.
00:10:00
Journey from Marine Biology to General Manager: A Career Evolution
00:10:00
Navigating Market Chaos: Strategic Steps for Investors | Michael J. Evans - Founder of Cogent Strategic Wealth
00:10:00
Advancements in Metal 3D Printing with Ric Fulop at DEVELOP3D LIVE USA 2017 | Ric Fulop - CEO of Desktop Metal
00:10:00
A VC fund focused on investing in AI, fintech, software infrastructure|Andrew Romans, Partner, 7BC Venture Capital
00:10:00
Get Financial Peace of Mind with a Quick Call to Deerfield Financial Advisors
00:10:00
Teemu Suna on Revolutionizing Healthcare with Metabolomics | Teemu Suna, CEO , Nightingale Health Oyj.
00:10:00
From Near Failure to $203M Success: Loom CEO Joe Thomas Shares Secrets of SaaS Scaling and Agility Amidst Uncertainty|Joe Thomas, CEO and Co-founder of Loom
00:10:00
John Canning Discusses Middle Market Private Equity Performance and Risks | John Canning, Chairman, Madison Dearborn Partners.
00:10:00
August 2022 Investment Committee Update: Navigating Bear Markets with Megan Trask, CFP®, and John Shanley, CFP® | Connecticut Wealth Management
00:10:00
Rafaela Resources: Driving Forward with Critical Metals Focus
00:10:00
Jean-Claude Maurel on Medesis Pharma’s Strategy for Controlling Inflammatory Cytokine Storms | Jean-Claude Maurel, CEO, Medesis Pharma SA.

© 2017 - Neuhu+